Cardiac MRI accurately quantified in vivo cardiac mass in mice, showing excellent agreement with postmortem heart weight (r = 0.996) and detecting dose-dependent hypertrophy.
Effect estimate: r = 0.996
With the development of recent transgenic techniques, studies involving mice offer opportunities to increase understanding of cardiac disease. This provides motivation for the current study to perform noninvasive evaluation of the normal and hypertrophied mouse heart with MRI. By acquiring ECG and respiratory signals, the MR image acquisition was gated to both the cardiac and respiratory cycles. Combining a spin-warp imaging sequence with an RF surface coil resulted in short-axis images that allowed quantification of in vivo cardiac mass. Excellent agreement between MRI-determined (y) and postmortem heart weight (x) was obtained: y = 0.991x + 1.43 (r = 0.996). Isoproterenol, at 282 micromol/kg body weight (BW) and 573 micromol/kg BW, induced a dose-dependent increase in the ratio of heart weight to BW of 16.8 +/- 1.09% and 24.1 +/- 1.71%, respectively, which was accurately measured by MRI. These results demonstrate the ability of MRI to noninvasively monitor cardiac anatomy in the mouse.
Slawson et al. (Mon,) conducted a other in Normal and hypertrophied mouse heart. Cardiac MRI vs. Postmortem heart weight was evaluated on Agreement between MRI-determined and postmortem heart weight (r = 0.996). Cardiac MRI accurately quantified in vivo cardiac mass in mice, showing excellent agreement with postmortem heart weight (r = 0.996) and detecting dose-dependent hypertrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: